CAS 122536-94-1 | ASIM-003 : Asimadoline

CAS 122536-94-1 | ASIM-003 : Asimadoline
(World's Largest Pharmaceutical Supplier)

  • CAS Number: 122536-94-1
  • Stock: 999g
  • Assay: 0.00%

Abstract:

CAS 122536-94-1 is a chemical compound with a molecular formula of C18H16N2O2S. It is commonly known as Febuxostat and is used to treat gout. This article will discuss the chemical properties and applications of CAS 122536-94-1.


1. Chemical Properties:

CAS 122536-94-1 is a white to off-white crystalline powder with a melting point of 223°C to 225°C. It is slightly soluble in water, ethanol, and methanol. Febuxostat is a xanthine oxidase inhibitor, which means it works by decreasing the amount of uric acid produced in the body.


2. Applications:

Febuxostat is primarily used to treat gout in adults. Gout is a type of arthritis that occurs when there is too much uric acid in the blood, which can lead to the formation of crystals in the joints. This can cause severe pain, swelling, and inflammation.


Febuxostat works by blocking the enzyme xanthine oxidase, which is responsible for producing uric acid. By reducing the amount of uric acid in the blood, Febuxostat can help prevent gout attacks and reduce the risk of developing tophi (lumps of uric acid crystals) in the joints.


In addition to treating gout, Febuxostat may also have potential applications in the treatment of other conditions. For example, some studies have suggested that it may be effective in treating hyperuricemia (high levels of uric acid in the blood) in patients with chronic kidney disease.


Conclusion:

CAS 122536-94-1, also known as Febuxostat, is a xanthine oxidase inhibitor that is commonly used to treat gout in adults. It works by reducing the amount of uric acid produced in the body, which can help prevent gout attacks and reduce the risk of developing tophi in the joints. Although primarily used for gout treatment, Febuxostat may have potential applications in the treatment of other conditions such as hyperuricemia in patients with chronic kidney disease.